Rigato et al., 2010
ViewHTML| Publication | Publication Date | Title |
|---|---|---|
| CN109152826B (en) | New vaccine against Zika virus | |
| US11167025B2 (en) | Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions | |
| TWI845955B (en) | Hiv vaccines and methods of making and using | |
| JP2009544333A (en) | Improved vaccine and method for using the same | |
| CN101990580A (en) | Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same | |
| TW202442670A (en) | Hiv vaccines and methods of using | |
| KR20190085917A (en) | Combinations of DNA vaccine constructs for use against new vaccines and Zikaviruses against Zicca viruses | |
| Qiu et al. | Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag | |
| Kabeya et al. | An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep | |
| Marsac et al. | Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles | |
| Letafati et al. | HTLV-1 vaccination Landscape: Current developments and challenges | |
| Goldoni et al. | Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice | |
| Rigato et al. | Immunization of neonatal mice with LAMP/p55 HIV gag DNA elicits robust immune responses that last to adulthood | |
| Ju et al. | Interleukin-21 administration leads to enhanced antigen-specific T cell responses and natural killer cells in HIV-1 vaccinated mice | |
| Godinho et al. | Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response | |
| Jiang et al. | HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-α | |
| Bagley et al. | Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin | |
| AU2013262426A1 (en) | Cellular vaccine and method of inducing an immune response in a subject | |
| US20130337009A1 (en) | Chimeric dna vaccine compositions and methods of use | |
| Gorse et al. | Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1SF-2 recombinant GP120 | |
| Rutkowski et al. | Defining the mechanism (s) of protection by cytolytic CD8 T cells against a cryptic epitope derived from a retroviral alternative reading frame | |
| Zickovich et al. | Agonistic anti-CD40 enhances the CD8+ T cell response during vesicular stomatitis virus infection | |
| US20180333481A1 (en) | Cross-reactive t-cell epitopes of hiv, siv, and fiv for vaccines in humans and cats | |
| Lucas et al. | Dendritic cells primed with a chimeric plasmid containing HIV‐1‐gag associated with lysosomal‐associated protein‐1 (LAMP/gag) is a potential therapeutic vaccine against HIV | |
| Gary | Enhancing the Immunogenicity of Anti-HIV DNA Vaccines with Molecular Adjuvants |